{"transactions":[{"id":1848547,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":112085,"kind":"person","name":"Fotopoulos Alexandros","position":1,"cik":"0001799814","reported_name":"Fotopoulos Alexandros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-06-20T20:10:44.000Z","date":"2023-06-15","kind":"exercise","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the RSUs vested on June 15, 2022, and the remainder vested or vests as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-23-038345","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919123038345/doc4.xml","form_type":"4"}},{"id":1848546,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":112085,"kind":"person","name":"Fotopoulos Alexandros","position":1,"cik":"0001799814","reported_name":"Fotopoulos Alexandros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2023-06-20T20:10:44.000Z","date":"2023-06-16","kind":"sale","planned":false,"acquired":false,"shares":4052,"price":0.9325,"value":3778.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a \"sell to cover\" transaction."}],"balance_after":28693,"source":{"system":"sec-edgar","filing":"0001209191-23-038345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919123038345/doc4.xml","form_type":"4"}},{"id":1848545,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":112085,"kind":"person","name":"Fotopoulos Alexandros","position":1,"cik":"0001799814","reported_name":"Fotopoulos Alexandros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2023-06-20T20:10:44.000Z","date":"2023-06-15","kind":"exercise","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":32745,"source":{"system":"sec-edgar","filing":"0001209191-23-038345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919123038345/doc4.xml","form_type":"4"}},{"id":1924472,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":112085,"kind":"person","name":"Fotopoulos Alexandros","position":1,"cik":"0001799814","reported_name":"Fotopoulos Alexandros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-05T23:27:05.000Z","date":"2023-03-15","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as of 1/48 of the total shares monthly beginning on April 15, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":175000,"derivative":{"exercise_price":1.08,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-23-023476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919123023476/doc4.xml","form_type":"4"}},{"id":2103993,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":112085,"kind":"person","name":"Fotopoulos Alexandros","position":1,"cik":"0001799814","reported_name":"Fotopoulos Alexandros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Restricted Stock Units","published_at":"2022-11-25T21:15:51.000Z","date":"2022-11-22","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The reported transaction represents the settlement of restricted stock units which vested on June 15, 2022 but for which settlement was delayed due to an inadvertent administrative error."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the RSUs vested on June 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-22-058795","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919122058795/doc4.xml","form_type":"4"}},{"id":2103992,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":112085,"kind":"person","name":"Fotopoulos Alexandros","position":1,"cik":"0001799814","reported_name":"Fotopoulos Alexandros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2022-11-25T21:15:51.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":3720,"price":1.33,"value":4947.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a \"sell to cover\" transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported total includes 3,082 shares of common stock the reporting person has acquired since the date of his last ownership report through the issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d)."}],"balance_after":20245,"source":{"system":"sec-edgar","filing":"0001209191-22-058795","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919122058795/doc4.xml","form_type":"4"}},{"id":2103991,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":112085,"kind":"person","name":"Fotopoulos Alexandros","position":1,"cik":"0001799814","reported_name":"Fotopoulos Alexandros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2022-11-25T21:15:51.000Z","date":"2022-11-22","kind":"exercise","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported total includes 3,082 shares of common stock the reporting person has acquired since the date of his last ownership report through the issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d)."}],"balance_after":23965,"source":{"system":"sec-edgar","filing":"0001209191-22-058795","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919122058795/doc4.xml","form_type":"4"}},{"id":2117329,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":112085,"kind":"person","name":"Fotopoulos Alexandros","position":1,"cik":"0001799814","reported_name":"Fotopoulos Alexandros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-11-14T21:21:43.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-056609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919122056609/doc4.xml","form_type":"4"}},{"id":2231013,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":112085,"kind":"person","name":"Fotopoulos Alexandros","position":1,"cik":"0001799814","reported_name":"Fotopoulos Alexandros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-15T21:21:41.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as of 1/36 of the total shares monthly beginning on July 13, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":2.29,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-22-037050","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919122037050/doc4.xml","form_type":"4"}},{"id":2396938,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":112085,"kind":"person","name":"Fotopoulos Alexandros","position":1,"cik":"0001799814","reported_name":"Fotopoulos Alexandros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-14T22:14:08.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":163900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests as to 1/48 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":163900,"derivative":{"exercise_price":4.52,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":163900},"source":{"system":"sec-edgar","filing":"0001787297-22-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000178729722000004/primary_doc.xml","form_type":"4"}},{"id":2704705,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":112085,"kind":"person","name":"Fotopoulos Alexandros","position":1,"cik":"0001799814","reported_name":"Fotopoulos Alexandros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2021-05-19T23:04:37.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the RSUs will vest on June 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1/4 of the RSUs will vest on June 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-034185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919121034185/doc4.xml","form_type":"4"}},{"id":2848606,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":112085,"kind":"person","name":"Fotopoulos Alexandros","position":1,"cik":"0001799814","reported_name":"Fotopoulos Alexandros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-19T00:24:27.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests as to 25% of the total shares on February 16, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":105000,"derivative":{"exercise_price":21.85,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001209191-21-012154","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919121012154/doc4.xml","form_type":"4"}},{"id":3230354,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":112085,"kind":"person","name":"Fotopoulos Alexandros","position":1,"cik":"0001799814","reported_name":"Fotopoulos Alexandros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2020-03-03T23:38:45.000Z","date":"2020-03-03","kind":"purchase","acquired":true,"shares":5500,"price":18,"value":99000.0,"ownership":{"direct":true},"balance_after":5500,"source":{"system":"sec-edgar","filing":"0001209191-20-015621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919120015621/doc4.xml","form_type":"4"}},{"id":3237020,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":112085,"kind":"person","name":"Fotopoulos Alexandros","position":1,"cik":"0001799814","reported_name":"Fotopoulos Alexandros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-02T22:50:43.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":74311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the total shares on February 27, 2021, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on February 27, 2024, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":74311,"derivative":{"exercise_price":18,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":74311},"source":{"system":"sec-edgar","filing":"0001209191-20-014691","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919120014691/doc4.xml","form_type":"4"}}]}